On July 15, 2024, LSL Pharma Group Inc closed the transaction. The company issued 2,400,000 units at a price of CAD 0.4 per Unit for total gross proceeds of CAD 960,000 in its final tranche. The Corporation was thus able to raise with both tranches a total of $2,450,800 in Financing.

In connection with this second and final tranche of the Financing, the Corporation paid to finders dealing at arm?s length with the Corporation, finders? fees for a total of CAD 14,600 in cash and issued 36,500 finders? warrants.

Each Finder?s Warrant entitles the holder to purchase one (1) Common Share at a price of CAD 0.70 for a period of 18 months following the closing date.